In a Policy Forum, Erin Sorrell and colleagues – a coalition of virologists, veterinarians, and health security experts – ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

MRNA's mRNA-1010 flu vaccine outperforms GSK's shot by 26.6% in a large phase III trial of adults 50 and older.

Trump and Musk reignite feud over tax bill, stocks end first half at records, Moderna flu vaccine achieves promising results, ...

Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

Amid promising signs, officials urged caution, noting that the outbreaks vary by clade, response measures, and social ...

Cambodia's health ministry yesterday reported two more human H5N1 avian flu cases, part of a spike in cases in June, with six ...

An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...